Levels of Gene Expression of Immunological Biomarkers in Peri-Implant and Periodontal Tissues
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Population
- PH group (n = 20): individuals with periodontal health;
- P group (n = 20): individuals with periodontitis;
- PIH group (n = 20): individuals with peri-implant health;
- PI group (n = 20): individuals with peri-implantitis.
2.2. Exclusion and Inclusion Criteria
- Use of antibiotics in the 6 months preceding the study;
- Use of corticosteroids, non-steroidal anti-inflammatory drugs, immunosuppressants, estrogen receptor modulators, or medications that can influence bone metabolism (alendronate, calcitonin, and others) during the 6 months prior to the study;
- Smoker or ex-smoker (previous 5 years);
- Individuals with diabetes, osteoporosis, immune disorders, hepatitis, or other systemic disorders that could compromise the individual’s defense response;
- Pregnant or lactating.
- Bleeding on probing and/or suppuration, with a probing depth (PD) >4 mm; radiographic bone loss greater than 3 mm, with at least 50% of peri-implant bone remaining (otherwise, implant was considered lost);
- Presenting at least one implant-supported prosthesis, using smooth-surface implants (commercially pure titanium), external hexagon and threadable, under function for at least 1 year, affected by peri-implantitis (if the individual had more than one implant affected by peri-implantitis, only one implant was evaluated);
- The absence of mobility, breakage of screws, or loosening of prosthetic components next to implant-supported prostheses, in order to minimize the influence of possible occlusal trauma.
- Minimum 15 teeth, excluding third molars and teeth indicated for extraction;
- Those with periodontitis stage III or IV, grade B or C, presenting at least 30% of the sites having PD and a clinical attachment level (CAL) ≥5 mm.
- Selected individuals with a PD and CAL ≤3 mm at all sites, without BoP, with indication for reconstructive/corrective surgery (PIH group) and gingivectomy or increased clinical crown (PH group).
2.3. Clinical and Radiographic Examination
- Presence (1) or absence (0) of a visible bacterial biofilm;
- Presence (1) or absence (0) of marginal bleeding (MB);
- Presence (1) or absence (0) of bleeding on probing;
- Presence (1) or absence (0) of suppuration (SUP);
- PD (mm)—characterized by the distance from the peri-implant margin or gingival margin to the bottom of the bag;
- CAL (mm)—characterized by the distance from a fixed point previously determined (connector/implant junction or bar in cases of overdentures or cement–enamel junction) to the bottom of the bag.
2.4. Gingival Tissue Sampling and Gene Expression Analysis
2.5. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Blanco, J.; Camargo, P.M.; Chen, S.; Cochran, D.; Derks, J.; Figuero, E.; Hämmerle, C.H.F.; Heitz-Mayfield, L.J.A.; Huynh-Ba, G.; Iacono, V.; et al. Peri-implant diseases and conditions: Consensus report of workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J. Clin. Periodontol. 2018, 45, S286–S291. [Google Scholar] [CrossRef] [Green Version]
- Shibli, J.A.; Melo, L.; Ferrari, D.S.; Figueiredo, L.C.; Faveri, M.; Feres, M. Composition of supra- and subgingival biofilm of subjects with healthy and diseased implants. Clin. Oral Implant. Res. 2008, 19, 975–982. [Google Scholar] [CrossRef] [PubMed]
- Mardegan, G.P.; Shibli, J.A.; Roth, L.A.; Faveri, M.; Giro, G.; Bastos, M.F. Transforming growth factor-b, interleukin-17, and IL-23 gene expression profiles associated with human peri-implantitis. Clin. Oral Implant. Res. 2017, 28, e10–e15. [Google Scholar] [CrossRef] [PubMed]
- Duarte, P.M.; Serrão, C.R.; Miranda, T.S.; Zanatta, L.C.; Bastos, M.F.; Faveri, M.; Figueiredo, L.C.; Feres, M. Could cytokine levels in the peri-implant crevicular fluid be used to distinguish between healthy implants and implants with peri-implantitis? A systematic review. J. Periodontal. Res. 2016, 51, 689–698. [Google Scholar] [CrossRef]
- Yucel-Lindberg, T.; Bage, T. Inflammatory mediators in the pathogenesis of periodontitis. Expert Rev. Mol. Med. 2013, 15, 7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Teixeira, M.K.S.; Lira-Junior, R.; Lourenço, E.J.V.; Telles, D.M.; Boström, E.A.; Figueredo, C.M.; Bostanci, N. The modulation of the TREM-1/PGLYRP1/MMP-8 axis in peri-implant diseases. Clin. Oral Investig. 2019. [Google Scholar] [CrossRef] [PubMed]
- Graves, D.T.; Oates, T.; Garlet, G.P. Review of osteoimmunology and the host response in endodontic and periodontal lesions. J. Oral Microbiol. 2011, 3, 1–15. [Google Scholar] [CrossRef] [PubMed]
- Chatzivasileiou, K.; Kriebel, K.; Steinhoff, G.; Kreikemeyer, B.; Lang, H. Do oral bacteria alter the regenerative potential of stem cells? A concise review. J. Cell. Mol. Med. 2015, 19, 2067–2074. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ramenzoni, L.; Russo, R.; Moccia, M.D.; Attin, T.; Schmidlin, P.R. Periodontal bacterial supernatants modify differentiation, migration and inflammatory cytokine expression in human periodontal. PLoS ONE 2019, 14, e0219181. [Google Scholar] [CrossRef]
- Quabius, E.S.; Ossenkop, L.; Harder, S.; Kern, M. Dental implants stimulate expression of Interleukin-8 and its receptor in human blood-An in vitro approach. J. Biomed. Mater. Res. B Appl. Biomater. 2012, 100, 1283–1288. [Google Scholar] [CrossRef]
- Mombelli, A.; Lang, N.P. The diagnosis and treatment of periimplantitis. Periodontol. 2000 1998, 17, 63–76. [Google Scholar] [CrossRef] [PubMed]
- Zhang, H.; Zhang, X.; Huang, J.I.E.; Fan, X. Identification of key genes and pathways for peri-implantitisthrough the analysis of gene expression data. Exp. Ther. Med. 2017, 13, 1832–1840. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Araujo, M.W.; Hovey, K.M.; Benedek, J.R.; Grossi, S.G.; Dorn, J.; Wactawski-Wende, J.; Genco, R.J.; Trevisan, M. Reproducibility of probing depth measurement using a constant-force electronic probe: Analysis of inter- and intraexaminer variability. J. Periodontol. 2003, 74, 1736–1740. [Google Scholar] [CrossRef] [PubMed]
- Duarte, P.M.; Miranda, T.S.; Lima, J.A.; Dias Gonçalves, T.E.; Santos, V.R.; Bastos, M.F.; Ribeiro, F.V. Expression of immune-inflammatory markers in sites of chronic periodontitis in patients with type 2 diabetes. J. Periodontol. 2012, 83, 426–434. [Google Scholar] [CrossRef]
- Bastos, M.F.; Tucci, M.A.; de Siqueira, A.; de Faveri, M.; Figueiredo, L.C.; Vallim, P.C.; Duarte, P.M. Diabetes may affect the expression of matrix metalloproteinases and their inhibitors more than smoking in chronic periodontitis. J. Periodontal. Res. 2017, 52, 292–299. [Google Scholar] [CrossRef]
- Belibasakis, G.N.; Manoil, D. Microbial Community-Driven Etiopathogenesis of Peri-Implantitis. J. Dent. Res. 2020, 12, 22034520949851. [Google Scholar] [CrossRef]
- Retamal-Valdes, B.; Formiga, M.C.; Almeida, M.L.; Fritoli, A.; Figueiredo, K.A.; Westphal, M.; Gomes, P.; Feres, M. Does subgingival bacterial colonization differ between implants and teeth? A systematic review. Braz. Oral Res. 2019, 33 (Suppl. S1), e064. [Google Scholar] [CrossRef]
- Heitz-Mayfield, L.J.; Lang, N.P. Comparative biology of chronic and aggressive periodontitis vs. peri-implantitis. Periodontol. 2000 2010, 53, 167–181. [Google Scholar] [CrossRef]
- Netea, M.G.; Simon, A.; van de Veerdonk, F.; Kullberg, B.J.; Van der Meer, J.W.; Joosten, L.A. IL-1beta processing in host defense: Beyond the inflammasomes. PLoS Pathog. 2010, 6, e1000661. [Google Scholar] [CrossRef] [Green Version]
- Ramadan, D.E.; Hariyani, N.; Indrawati, R.; Ridwan, R.D.; Diyatri, I. Cytokines and Chemokines in Periodontitis. Eur. J. Dent. 2020, 14, 483–495. [Google Scholar] [CrossRef]
- Ghassib, I.; Chen, Z.; Zhu, J.; Wang, H.L. Use of IL-1 β, IL-6, TNF-α, and MMP-8 biomarkers to distinguish peri-implant diseases: A systematic review and meta-analysis. Clin. Implant. Dent. Relat. Res. 2019, 21, 190–207. [Google Scholar] [CrossRef] [PubMed]
- Tallant, C.; Marrero, A.; Gomis-Rüth, F.X. Matrix metalloproteinases: Fold and function of their catalytic domains. Biochim. Biophys. Acta 2010, 1803, 20–28. [Google Scholar] [CrossRef] [PubMed]
- Trengove, N.J.; Stacey, M.C.; MacAuley, S.; Bennett, N.; Gibson, J.; Burslem, F.; Murphy, G.; Schultz, G. Analysis of the acute and chronic wound environments: The role of proteases and their inhibitors. Wound Repair Regen. 1999, 7, 442–452. [Google Scholar] [CrossRef] [PubMed]
- Gill, S.E.; Parks, W.C. Metalloproteinases and their inhibitors: Regulators of would healing. Int. J. Biochem. Cell Biol. 2008, 40, 1334–1347. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- D’Armiento, J.; Dalal, S.S.; Okada, Y.; Berg, R.A.; Chada, K. Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell 1992, 71, 955–961. [Google Scholar] [CrossRef]
- Molloy, K.J.; Thompson, M.M.; Schwalbe, E.C.; Bell, P.R.; Naylor, A.R.; Loftus, I.M. Elevation in plasma MMP-9 following carotid endarterectomy is associated with particulate cerebral embolisation. Eur. J. Vasc. Endovasc. Surg. 2004, 27, 409–413. [Google Scholar] [CrossRef] [Green Version]
- Dozier, S.; Escobar, G.P.; Lindsey, M.L. Matrix metalloproteinase (MMP)-7 activates MMP-8 but not MMP-13. Med. Chem. 2006, 2, 523–526. [Google Scholar] [CrossRef]
- Koch, S.; Volkmar, C.M.; Kolb-Bachofen, V.; Korth, H.G.; Kirsch, M.; Horn, A.H.; Sticht, H.; Pallua, N.; Suschek, C.V. A new redox-dependent mechanism of MMP-1 activity control comprising reduced low-molecular-weight thiols and oxidizing radicals. J. Mol. Med. 2009, 87, 261–272. [Google Scholar] [CrossRef]
- Checchi, V.; Maravic, T.; Bellini, P.; Generali, L.; Consolo, U.; Breschi, L.; Mazzoni, A. The Role of Matrix Metalloproteinases in Periodontal Disease. Int. J. Environ. Res. Public Health 2020, 17, 4923. [Google Scholar] [CrossRef]
- Marcaccini, A.M.; Novaes, A.B., Jr.; Meschiari, C.A.; Souza, S.L.; Palioto, D.B.; Sorgi, C.A.; Faccioli, L.H.; Tanus-Santos, J.E.; Gerlach, R.F. Circulating matrix metalloproteinase-8 (MMP-8) and MMP-9 are increased in chronic periodontal disease and decrease after non-surgical periodontal therapy. Clin. Chim. Acta 2009, 409, 117–122. [Google Scholar] [CrossRef]
- Marcaccini, A.M.; Meschiari, C.A.; Zuardi, L.R.; de Sousa, T.S.; Taba, M., Jr.; Teofilo, J.M.; Jacob-Ferreira, A.L.; Tanus-Santos, J.E.; Novaes, A.B., Jr.; Gerlach, R.F. Gingival crevicular fluid levels of MMP-8, MMP-9, TIMP-2, and MPO decrease after periodontal therapy. J. Clin. Periodontol. 2010, 37, 180–190. [Google Scholar] [CrossRef] [PubMed]
- Gursoy, U.K.; Könönen, E.; Pradhan-Palikhe, P.; Tervahartiala, T.; Pussinen, P.J.; Suominen-Taipale, L.; Sorsa, T. Salivary MMP-8, TIMP-1, and ICTP as markers of advanced periodontitis. J. Clin. Periodontol. 2010, 37, 487–493. [Google Scholar] [CrossRef] [PubMed]
- Sorsa, T.; Hernández, M.; Leppilahti, J.; Munjal, S.; Netuschil, L.; Mäntylä, P. Detection of gingival crevicular fluid MMP-8 levels with different laboratory and chair-side methods. Oral Dis. 2010, 16, 39–45. [Google Scholar] [CrossRef] [PubMed]
- Ramseier, C.A.; Eick, S.; Brönnimann, C.; Buser, D.; Brägger, U.; Salvi, G.E. Host-derived biomarkers at teeth and implants in partially edentulous patients. A 10-year retrospective study. Clin. Oral Implant. Res. 2016, 27, 211–217. [Google Scholar] [CrossRef] [PubMed]
- Alassiri, S.; Parnanen, P.; Rathnayake, N.; Johannsen, G.; Heikkinen, A.M.; Lazzara, R.; van der Schoor, P.; van der Schoor, J.G.; Tervahartiala, T.; Gieselmann, D.; et al. The Ability of Quantitative, Specific, and Sensitive Point-of-Care/Chair-Side Oral Fluid Immunotests for aMMP-8 to Detect Periodontal and Peri-Implant Diseases. Dis. Markers 2018, 5, 1306396. [Google Scholar] [CrossRef]
- Nomura, T.; Ishii, A.; Shimizu, H.; Taguchi, N.; Yoshie, H.; Kusakari, H.; Hara, K. Tissue inhibitor of metalloproteinases-1, matrix metalloproteinases-1 and -8, and collagenase activity levels in peri-implant crevicular fluid after implantation. Clin. Oral Implant. Res. 2000, 11, 430–440. [Google Scholar] [CrossRef]
- Arakawa, H.; Uehara, J.; Hara, E.S.; Sonoyama, W.; Kimura, A.; Kanyama, M.; Matsuka, Y.; Kuboki, T. Matrix metalloproteinase-8 is the major potential collagenase in active peri-implantitis. J. Prosthodont. Res. 2012, 56, 249–255. [Google Scholar] [CrossRef] [Green Version]
- Janska, E.; Mohr, B.; Wahl, G. Correlation between peri-implantar sulcular fluid rate and expression of collagenase2 (MMP8). Clin. Oral Investig. 2016, 20, 261–266. [Google Scholar] [CrossRef]
- Kensara, A.; Hefni, E.; Williams, M.A.; Saito, H.; Mongodin, E.; Masri, R. Microbiological Profile and Human Immune Response Associated with Peri-Implantitis: A Systematic Review. J. Prosthodont. 2020, 5. [Google Scholar] [CrossRef]
Biomarkers | Sequence | Amplification Profile (Temperature (°C)/Time (s)) | Length of PCR Product (bp) |
---|---|---|---|
IL-6 | 5′ GCAGGACATGACAACTCATC 3′ AAGTTCTGTGCCCAGTGG | 95/10, 56/5, 72/6 | 159 |
IL-1ß | 5′ CACCTTCTTTCCCTTCATCTTTG 3′ GCTTTCAGTTCATATGGACCAG | 95/10, 56/5, 72/7 | 158 |
TNF-α | 5′ CCAGGGACCTCTCTCTAATCA 3′ CTGGTTATCTCTCAGCTCCAC | 95/10, 56/5, 72/7 | 178 |
MMP-1 | 5′ AGCTGCTTACGAATTTGCC 3′ GCAGCATCGATATGCTTCAC | 95/10, 55/10, 72/7 | 136 |
MMP-2 | 5′ CGCAGATGCCTGGAATG 3′ GTCGGATTTGATGCTTCCAAAC | 95/10, 55/10, 72/7 | 151 |
MMP-8 | 5′ CTAGACAGTACCCTTGGCC 3′ CTGCAAAGACCCTGGTAAG | 95/10, 55/10, 72/7 | 154 |
MMP-9 | 5′ GCTACCACCTCGAACTTTGAC 3′ CTCAGTGAAGCGGTACATAGG | 95/10, 56/10, 72/7 | 162 |
TIMP-1 | 5′ CAGACCACCTTATACCAGCG 3′ CCAGCAATGAGAAACTCCTC | 95/10, 55/10, 72/7 | 145 |
TIMP-2 | 5′ CTGGGAGGGTATCCAGGAATC 3′ CACCATACAGGAAGCGAAC | 95/10, 56/10, 72/7 | 169 |
GAPDH | 5′ CTGAGTACGTCGTGGAGTC 3′ TGATGATCTTGAGGCTGTTGTC | 95/10, 56/10, 72/7 | 187 |
Parameters | Groups | |||
---|---|---|---|---|
PH | P | PIH | PI | |
Gender (M/F) * | 09/11 | 10/10 | 10/10 | 8/12 |
Age (years) | 41.6 ± 4.4 | 43.2 ± 7.1 | 42.7 ± 4.3 | 44.8 ± 3.9 |
% of sites with visible plaque | 31.7 ± 12.8 A | 57.5 ± 12.3 B | 34.2 ± 13.7 A | 50.3 ± 10.8 B |
% of sites with MB | 7.3 ± 2.8 A | 51.8 ± 8.3 B | 5.2 ± 2.2 A | 48.7 ± 9.1 B |
% of sites with BoP | 14.7 ± 5.5 A | 72.9 ± 16.1 B | 12.1 ±5.1 A | 82.3 ± 17.3 B |
PD (mm) | 2.2 ± 0.3 A | 3.74 ± 0.7 B | 2.6 ± 0.8 A | 5.5 ± 1.2 B |
CAL (mm) | 2.3 ± 0.4 A | 4.23 ± 0.8 B | 2.7 ± 0.3 A | 5.8 ± 1.3 B |
% of sites with suppuration | 0.00 ± 0.0 A | 2.7 ± 0.9 B | 0.00 ± 0.0 A | 3.1 ± 0.1 B |
Biomarkers | Groups | |||
---|---|---|---|---|
PH | P | PIH | PI | |
IL-1ß | 0.0 ± 0.0 B | 0.0 ± 0.01 B | 0.0 ± 0.0 B | 0.2 ± 0.4 A |
IL-6 | 0.1 ± 0.2 A | 2.3 ± 4.1 B | 0.2 ± 0.1 A | 7.8 ± 1.7 B |
TNF-α | 0.1 ± 0.2 | 1.9 ± 4.7 | 0.0 ± 0.1 | 1.3 ± 3.9 |
MMP-1 | 1.4 ± 4.3 | 1.30 + 0.10 | 0.90 + 0.10 | 1.20 + 0.20 |
MMP-2 | 4.7 ± 0.3 | 5.9 + 0.1 | 4.9 + 0.1 | 6.2 + 0.2 |
MMP-8 | 0.2 ± 0.1 | 0.4 ± 0.1 | 0.1 + 0.1 | 0.3 + 0.2 |
MMP-9 | 0.6 ± 0.1 | 3.4 ± 0.9 | 2.3 ± 5.3 | 3.7 ± 0.6 |
TIMP-1 | 6.8 + 0.1 | 8.6 + 0.1 | 6.6 + 0.2 | 8.1 + 0.3 |
TIMP-2 | 0.7 ± 0.1 | 2.0 ± 5.30 | 0.5 + 0.2 | 1.3 ± 0.3 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Figueiredo, L.C.; Bueno-Silva, B.; Nogueira, C.F.P.; Valadares, L.C.; Garcia, K.M.M.; Filho, G.C.d.L.; Milanello, L.; Esteves, F.M.; Shibli, J.A.; Miranda, T.S. Levels of Gene Expression of Immunological Biomarkers in Peri-Implant and Periodontal Tissues. Int. J. Environ. Res. Public Health 2020, 17, 9100. https://doi.org/10.3390/ijerph17239100
Figueiredo LC, Bueno-Silva B, Nogueira CFP, Valadares LC, Garcia KMM, Filho GCdL, Milanello L, Esteves FM, Shibli JA, Miranda TS. Levels of Gene Expression of Immunological Biomarkers in Peri-Implant and Periodontal Tissues. International Journal of Environmental Research and Public Health. 2020; 17(23):9100. https://doi.org/10.3390/ijerph17239100
Chicago/Turabian StyleFigueiredo, Luciene Cristina, Bruno Bueno-Silva, Cristiana Fernandes Plutarco Nogueira, Leonardo Carneiro Valadares, Katia Marina Morilla Garcia, Givelton Coimbra da Luz Filho, Luciano Milanello, Felipe Machado Esteves, Jamil Awad Shibli, and Tamires Szeremeske Miranda. 2020. "Levels of Gene Expression of Immunological Biomarkers in Peri-Implant and Periodontal Tissues" International Journal of Environmental Research and Public Health 17, no. 23: 9100. https://doi.org/10.3390/ijerph17239100
APA StyleFigueiredo, L. C., Bueno-Silva, B., Nogueira, C. F. P., Valadares, L. C., Garcia, K. M. M., Filho, G. C. d. L., Milanello, L., Esteves, F. M., Shibli, J. A., & Miranda, T. S. (2020). Levels of Gene Expression of Immunological Biomarkers in Peri-Implant and Periodontal Tissues. International Journal of Environmental Research and Public Health, 17(23), 9100. https://doi.org/10.3390/ijerph17239100